IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,224,000 | +35.1% | 195,492 | +11.4% | 0.59% | +45.5% |
| Q4 2021 | $5,347,000 | -9.2% | 175,508 | 0.0% | 0.41% | -8.7% |
| Q3 2021 | $5,888,000 | -20.0% | 175,508 | -4.9% | 0.45% | -7.9% |
| Q2 2021 | $7,361,000 | +34.5% | 184,462 | +51.6% | 0.48% | +21.9% |
| Q1 2021 | $5,474,000 | -15.0% | 121,699 | +6.9% | 0.40% | -19.5% |
| Q4 2020 | $6,442,000 | +48.1% | 113,836 | +24.3% | 0.49% | +52.2% |
| Q3 2020 | $4,350,000 | -14.4% | 91,617 | +6.4% | 0.32% | -16.5% |
| Q2 2020 | $5,079,000 | +30.1% | 86,123 | +4.5% | 0.39% | +7.5% |
| Q1 2020 | $3,904,000 | -22.6% | 82,377 | -1.2% | 0.36% | -1.6% |
| Q4 2019 | $5,042,000 | +18.7% | 83,370 | +17.7% | 0.37% | +1.9% |
| Q3 2019 | $4,249,000 | -17.1% | 70,856 | -11.0% | 0.36% | -8.4% |
| Q2 2019 | $5,128,000 | -17.8% | 79,651 | +3.7% | 0.39% | -10.7% |
| Q1 2019 | $6,238,000 | +13.9% | 76,785 | -22.5% | 0.44% | +7.8% |
| Q4 2018 | $5,475,000 | -13.3% | 99,045 | -19.1% | 0.41% | -14.3% |
| Q3 2018 | $6,316,000 | +45.5% | 122,452 | +17.5% | 0.48% | +41.7% |
| Q2 2018 | $4,342,000 | +7.4% | 104,199 | +13.6% | 0.34% | -8.7% |
| Q1 2018 | $4,042,000 | -0.4% | 91,699 | +13.6% | 0.37% | +8.2% |
| Q4 2017 | $4,059,000 | +7.9% | 80,696 | +8.8% | 0.34% | +11.1% |
| Q3 2017 | $3,762,000 | -0.3% | 74,196 | 0.0% | 0.31% | -14.5% |
| Q2 2017 | $3,774,000 | +26.5% | 74,196 | 0.0% | 0.36% | +12.2% |
| Q1 2017 | $2,983,000 | -7.0% | 74,196 | +10.6% | 0.32% | -25.6% |
| Q4 2016 | $3,208,000 | +231.1% | 67,068 | +153.6% | 0.43% | +176.8% |
| Q3 2016 | $969,000 | +82.8% | 26,450 | +16.3% | 0.16% | +78.2% |
| Q2 2016 | $530,000 | -33.8% | 22,750 | +15.2% | 0.09% | -25.6% |
| Q1 2016 | $800,000 | -8.9% | 19,751 | +39.4% | 0.12% | -3.3% |
| Q4 2015 | $878,000 | – | 14,173 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |